Abuse of anticholinergic drugs. 1978

J S Rubinstein

UI MeSH Term Description Entries
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014282 Trihexyphenidyl One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic. Benzhexol,Apo-Trihex,Artane,Cyclodol,Hipokinon,Parkinane,Parkopan,Trihexane,Trihexidyl Hydrochloride,Trihexyphenidyl Hydrochloride,Trihexyphenidyl Hydrochloride Elixir,Apo Trihex,ApoTrihex
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

J S Rubinstein
June 1981, Harefuah,
J S Rubinstein
January 1984, The Hillside journal of clinical psychiatry,
J S Rubinstein
January 1990, DICP : the annals of pharmacotherapy,
J S Rubinstein
October 1990, Nederlands tijdschrift voor geneeskunde,
J S Rubinstein
March 1990, Nederlands tijdschrift voor geneeskunde,
J S Rubinstein
February 1957, Annals of internal medicine,
J S Rubinstein
January 1963, Revista brasileira de gastroenterologia,
J S Rubinstein
July 1979, British journal of anaesthesia,
J S Rubinstein
January 1964, The Practitioner,
J S Rubinstein
January 1963, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!